Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

As the incidence of lung cancer in the elderly is increasing worldwide, there exists a need to develop a clinically effective, less toxic therapy for this patient population. Although erlotinib has shown proven effectiveness against non-small cell lung cancer (NSCLC), few studies have prospectively investigated its application to elderly patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Anticancer Res.

Title: Anticancer research

ISSN (Electronic): 1791-7530

ISSN (Print): 0250-7005

Publication date (Electronic): Jun 2016

Volume: 36

Issue: 6

Affiliations

[1 ] Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan kayamada@med.kurume-u.ac.jp.

[2 ] Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.

[3 ] Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Fukuoka, Japan.

[4 ] Department of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.

[5 ] Department of Respiratory Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.

[6 ] Department of Respiratory Medicine, Sendai Medical Association Hospital, Kagoshima, Japan.

[7 ] Department of Respiratory Medicine, Japan Community Health care Organization Isahaya General Hospital, Nagasaki, Japan.

[8 ] Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

[9 ] Department of Respiratory Medicine, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.

[10 ] Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

[11 ] Department of Clinical Research Promotion, Kyushu University Hospital, Fukuoka, Japan.

[12 ] Department of Thoracic and Breast Surgery, Oita University, Oita, Japan.

Article

Publisher Item ID: 36/6/2881

PubMed ID: 27272800

SO-VID: 872eefa9-f84a-40f3-ab95-0555368c36b2

History

Keywords: EGFR,Erlotinib,unselected,non-small cell lung cancer

Data availability:

Keywords: EGFR, Erlotinib, unselected, non-small cell lung cancer

Comments

Comment on this article

Cited by 5

See all cited by